000 | 01353 a2200361 4500 | ||
---|---|---|---|
005 | 20250515012653.0 | ||
264 | 0 | _c20060919 | |
008 | 200609s 0 0 eng d | ||
022 | _a0305-1870 | ||
024 | 7 |
_a10.1111/j.1440-1681.2005.04297.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBateman, D N | |
245 | 0 | 0 |
_aClinical toxicology: clinical science to public health. _h[electronic resource] |
260 |
_bClinical and experimental pharmacology & physiology _cNov 2005 |
||
300 |
_a995-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnalgesics, Opioid _xpoisoning |
650 | 0 | 4 |
_aAntipsychotic Agents _xpoisoning |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xetiology |
650 | 0 | 4 |
_aDextropropoxyphene _xpoisoning |
650 | 0 | 4 | _aDrug Information Services |
650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPharmacology, Clinical _xmethods |
650 | 0 | 4 | _aPoison Control Centers |
650 | 0 | 4 | _aPublic Health |
650 | 0 | 4 | _aScotland |
650 | 0 | 4 |
_aThioridazine _xpoisoning |
650 | 0 | 4 |
_aToxicology _xtrends |
773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 32 _gno. 11 _gp. 995-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1681.2005.04297.x _zAvailable from publisher's website |
999 |
_c16022451 _d16022451 |